ReviewClinical and experimental immunology2014
Requirement for safety monitoring for approved multiple sclerosis therapies: an overview.
P S Rommer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
32 papers cite it
this paperpooled itcites it